Literature DB >> 34331386

Auditory and olfactory findings in patients with USH2A-related retinal degeneration-Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A).

Alessandro Iannaccone1, Carmen C Brewer2, Peiyao Cheng3, Jacque L Duncan4, Maureen G Maguire5, Isabelle Audo6,7, Allison R Ayala3, Paul S Bernstein8, Gavin M Bidelman9, Janet K Cheetham10, Richard L Doty5, Todd A Durham10, Robert B Hufnagel11, Mark H Myers12, Katarina Stingl13,14, Wadih M Zein11.   

Abstract

Sensorineural hearing loss (SNHL) is characteristic of Usher syndrome type 2 (USH2), but less is known about SNHL in nonsyndromic autosomal recessive retinitis pigmentosa (ARRP) and olfaction in USH2A-associated retinal degeneration. The Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) is a natural history study that enrolled 127 participants, 80 with USH2 and 47 with ARRP. Hearing was measured by pure-tone thresholds and word recognition scores, and olfaction by the University of Pennsylvania Smell Identification Test (UPSIT). SNHL was moderate in 72% of USH2 participants and severe or profound in 25%, while 9% of ARRP participants had moderate adult-onset SNHL. Pure-tone thresholds worsened with age in ARRP but not in USH2 participants. The degree of SNHL was not associated with other participant characteristics in either USH2 or ARRP. Median pure-tone thresholds in ARRP participants were significantly higher than the normative population (p < 0.001). Among 14 USH2 participants reporting newborn hearing screening results, 7 reported passing. Among RUSH2A participants, 7% had mild microsmia and 5% had moderate or severe microsmia. Their mean (±SD) UPSIT score was 35 (±3), similar to healthy controls (34 [±3]; p = 0.39). Olfaction differed by country (p = 0.02), but was not significantly associated with clinical diagnosis, age, gender, race/ethnicity, smoking status, visual measures, or hearing. Hearing loss in USH2A-related USH2 did not progress with age. ARRP patients had higher pure-tone thresholds than normal. Newborn hearing screening did not identify all USH2A-related hearing loss. Olfaction was not significantly worse than normal in participants with USH2A-related retinal degeneration.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  Usher syndrome type 2; autosomal recessive retinitis pigmentosa; olfaction; sensorineural hearing loss

Mesh:

Substances:

Year:  2021        PMID: 34331386      PMCID: PMC8717864          DOI: 10.1002/ajmg.a.62437

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.578


  46 in total

1.  Usher syndrome type III: revised genomic structure of the USH3 gene and identification of novel mutations.

Authors:  Randall R Fields; Guimei Zhou; Dali Huang; Jack R Davis; Claes Möller; Samuel G Jacobson; William J Kimberling; Janos Sumegi
Journal:  Am J Hum Genet       Date:  2002-07-16       Impact factor: 11.025

Review 2.  Usher syndrome: hearing loss with vision loss.

Authors:  Thomas B Friedman; Julie M Schultz; Zubair M Ahmed; Ekaterini T Tsilou; Carmen C Brewer
Journal:  Adv Otorhinolaryngol       Date:  2011-02-24

3.  ISCEV Standard for full-field clinical electroretinography (2015 update).

Authors:  Daphne L McCulloch; Michael F Marmor; Mitchell G Brigell; Ruth Hamilton; Graham E Holder; Radouil Tzekov; Michael Bach
Journal:  Doc Ophthalmol       Date:  2014-12-14       Impact factor: 2.379

4.  Missense mutation in the USH2A gene: association with recessive retinitis pigmentosa without hearing loss.

Authors:  C Rivolta; E A Sweklo; E L Berson; T P Dryja
Journal:  Am J Hum Genet       Date:  2000-04-20       Impact factor: 11.025

5.  Clinical evidence of decreased olfaction in Bardet-Biedl syndrome caused by a deletion in the BBS4 gene.

Authors:  Alessandro Iannaccone; Kirk Mykytyn; Antonio M Persico; Charles C Searby; Alfonso Baldi; Monica M Jablonski; Val C Sheffield
Journal:  Am J Med Genet A       Date:  2005-02-01       Impact factor: 2.802

6.  New visual acuity charts for clinical research.

Authors:  F L Ferris; A Kassoff; G H Bresnick; I Bailey
Journal:  Am J Ophthalmol       Date:  1982-07       Impact factor: 5.258

7.  Bbs2-null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin.

Authors:  Darryl Y Nishimura; Melissa Fath; Robert F Mullins; Charles Searby; Michael Andrews; Roger Davis; Jeaneen L Andorf; Kirk Mykytyn; Ruth E Swiderski; Baoli Yang; Rivka Carmi; Edwin M Stone; Val C Sheffield
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-11       Impact factor: 11.205

8.  Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing.

Authors:  Maho Oishi; Akio Oishi; Norimoto Gotoh; Ken Ogino; Koichiro Higasa; Kei Iida; Yukiko Makiyama; Satoshi Morooka; Fumihiko Matsuda; Nagahisa Yoshimura
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-16       Impact factor: 4.799

9.  Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function.

Authors:  R L Doty; P Shaman; M Dann
Journal:  Physiol Behav       Date:  1984-03

10.  Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa.

Authors:  J D Eudy; M D Weston; S Yao; D M Hoover; H L Rehm; M Ma-Edmonds; D Yan; I Ahmad; J J Cheng; C Ayuso; C Cremers; S Davenport; C Moller; C B Talmadge; K W Beisel; M Tamayo; C C Morton; A Swaroop; W J Kimberling; J Sumegi
Journal:  Science       Date:  1998-06-12       Impact factor: 47.728

View more
  1 in total

1.  Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A study.

Authors:  Robert B Hufnagel; Wendi Liang; Jacque L Duncan; Carmen C Brewer; Isabelle Audo; Allison R Ayala; Kari Branham; Janet K Cheetham; Stephen P Daiger; Todd A Durham; Bin Guan; Elise Heon; Carel B Hoyng; Alessandro Iannaccone; Christine N Kay; Michel Michaelides; Mark E Pennesi; Mandeep S Singh; Ehsan Ullah
Journal:  Hum Mutat       Date:  2022-03-21       Impact factor: 4.700

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.